Improved glucometrics in people with type 1 diabetes 1 year into the COVID-19 pandemic
10.1136/bmjdrc-2022-002789
May 20, 2022
COVID-19
Temporal trends in hospitalizations due to diabetes complications during COVID-19 pandemic in Andalusia, Spain
10.1136/bmjdrc-2021-002623
March 29, 2022
Long-term follow-up of a randomized clinical trial comparing glycemic excursion minimization (GEM) to weight loss (WL) in the management of type 2 diabetes
10.1136/bmjdrc-2021-002403
November 29, 2021
Validation and feasibility of a postal system for remote monitoring of HbA1c
10.1136/bmjdrc-2021-002527
November 15, 2021
High-dose insulin infusion in patients with COVID-19
10.1136/bmjdrc-2021-002415
November 11, 2021
Evaluation and management of COVID-19-related severity in people with type 2 diabetes
10.1136/bmjdrc-2021-002299
September 7, 2021
Exploring support needs of people living with diabetes during the coronavirus COVID-19 pandemic: insights from a UK survey
10.1136/bmjdrc-2021-002162
June 7, 2021
Risk factors for adverse outcomes among 35 879 veterans with and without diabetes after diagnosis with COVID-19
10.1136/bmjdrc-2021-002252
June 3, 2021
Lack of association between either outpatient or inpatient glycemic control and COVID-19 illness severity or mortality in patients with diabetes
10.1136/bmjdrc-2021-002203
May 31, 2021
Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection
10.1136/bmjdrc-2020-002026
February 16, 2021